Women in the lowest versus the highest tertile of the MedDietScore had significantly lower rates of clinical pregnancy (29.1 versus 50.0%) and live birth (26.6 versus 48.8%).
The researchers found that the risk of surgical complications was lower for hysteroscopic sterilization during the hospitalization for sterilization (0.13 versus 0.78%; adjusted risk difference, −0.64).
Those with moderate-to-severe deficiency (iodine-creatinine ratios <50 μg/g) had a 46% reduction in fecundity versus those whose iodine-creatinine ratios were in the adequate range (adjusted fecundability odds ratio of becoming pregnant per cycle, 0.54).
The researchers found that the time to ovulation was decreased in the stair-step versus the traditional protocol (23.1 ± 0.9 versus 47.5 ± 6.3 days).
The Lia Pregnancy Test is made with the same plant based fibers as most toilet paper and weighs less than 6 squares of the leading 3-ply toilet paper.
The researchers found that live birth was more likely in women replete with vitamin D versus those with vitamin D deficiency or insufficiency.
GONAL-f (follitropin alfa injection) is a recombinant human follicle-stimulating hormone (r-hFSH) approved for the treatment female infertility and a rare form of male infertility.
The data indicated little association between vaccination in females (FR 0.98, 95% CI: 0.90, 1.08) or males (FR 1.07, 95% CI: 0.79, 1.46) and fecundability.
The study included 1,119 women being treated for infertility who had their fallopian tubes flushed with either iodized poppy seed oil or water.
"This is the first study that demonstrates that scaffold architecture makes a difference in follicle survival," said one of the lead researchers Dr. Ramille Shah.
The presence of a non-Lactobacillus-dominated microbiota in a receptive endometrium is associated with poor reproductive outcomes for women undergoing in vitro fertilization (IVF).
Patients undergoing fertility treatment often suffer symptoms of depression or anxiety, but few get any formal help, according to research published in Fertility and Sterility.
A bracelet that can track a woman's fertility has been launched today by the medical technology company Ava. In clinical trials the bracelet (which is worn only at night), detected an average of 5.3 fertile days per cycle with 89% accuracy.
Women who undergo in vitro fertilization (IVF) are not at increased risk of breast cancer, according to a study published in the issue of the Journal of the American Medical Association.
Results of in vitro fertilization (IVF) cycles using eggs from older donors are as good as those using eggs from younger women.
For cancer survivors, ovarian tissue transplants are safe and effective and pose little risk of cancer recurrence, according to a report published in Human Reproduction.
Use of letrozole (Femara) may reduce a couple's risk of having a pregnancy with multiple embryos - but it might also slightly lower their chances of a live birth, a new clinical trial suggests.
In vitro fertilization (IVF) with cryopreserved donor oocytes has lower cancellation rates and lower live birth rates compared with donor cycles using fresh oocytes.
Women who conceive following in vitro fertilization (IVF) are significantly more likely to develop gastroesophageal reflux disease (GERD) at least one year after delivery, although the risk does not vary with singleton and twin births, according to a study in the United European Gastroenterology Journal.
For women with breast cancer, embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility, according to a study published in the Journal of Clinical Oncology.
A study presented at the European League Against Rheumatism Annual Congress (EULAR 2015) indicates that use of some non-steroidal anti-inflammatory drugs (NSAIDs) could have a negative impact on female fertility, even with short-term use.